How much should we know about a CEO's health?
At the end of a marathon day in Balocco, Italy, in June, Sergio Marchionne was still going strong. Marchionne, the CEO of Fiat Chrysler Automobiles, died less than two months later. In the days after his death, the Swiss hospital where he died said Marchionne had been treated over the previous year for an undisclosed serious illness, and questions were being raised about what company officials knew. But if the FCA board knew of Marchionne's struggles — and that's not a certainty — is there a requirement to share more? Professor Sudip Datta, finance department chair at Wayne State University's Mike Ilitch School of Business, said the issue goes to privacy. "There's no requirement per se about disclosing the health of the CEO to investors," Datta said, "Just because someone is a CEO, it doesn't mean someone checks all his privacy at the door." The U.S. Securities and Exchange Commission "doesn’t say you have to disclose the private lives of the CEO or for that matter any employee," Datta said.